Home › Macular Edema › Texas › Austin
Macular Edema clinical trials in Austin, TX
4 studies for Macular Edema are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
RecruitingPhase 3
- Austin Research Center for Retina ( Site 0033), Austin
- Austin Retina Associates ( Site 0008), Austin
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
RecruitingPhase 2
- Austin Research Center for Retina, PLLC, Austin
- Austin Retina Associates, Austin
- Austin Clinical Research, LLC, Austin
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
RecruitingPhase 3
- Austin Retina Associates, PLLC (Austin), Austin
- UT Austin, Austin
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
RecruitingPhase 3
- Austin Retina Associates, PLLC (Austin), Austin
- UT Austin, Austin
Macular Edema trials in other cities
- Carmel, IN5 studies
- Hagerstown, MD5 studies
- San Antonio, TX5 studies
- Sacramento, CA4 studies
- The Woodlands, TX4 studies
- Raleigh, NC4 studies
- Phoenix, AZ4 studies
- Houston, TX3 studies
- Hartford, CT3 studies
- Plano, TX3 studies
- Columbia, SC3 studies
- Glendale, CA3 studies
Other studies in Austin
- Non-Small Cell Lung Cancer29 studies
- Cancer (all types)22 studies
- Obesity22 studies
- Overweight19 studies
- Metastatic Cancer18 studies
- Colorectal Cancer17 studies
- Ovarian Cancer17 studies
- Heart Failure17 studies
- Endometrial Cancer15 studies
- Breast Cancer15 studies
- Type 2 Diabetes14 studies
- Prostate Cancer14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.